{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:35:12Z","timestamp":1790649312987,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T00:00:00Z","timestamp":1448841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/aps.2015.89","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T10:01:08Z","timestamp":1448877668000},"page":"143-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Cancer predisposition genes: molecular mechanisms and clinical impact on personalized cancer care: examples of Lynch and HBOC syndromes"],"prefix":"10.1038","volume":"37","author":[{"given":"Qing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,30]]},"reference":[{"key":"BFaps201589_CR1","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1001\/archinte.1913.00070050063006","volume":"12","author":"AS Warthin","year":"1913","unstructured":"Warthin AS . Heredity with reference to carcinoma. Arch Intern Med 1913; 12: 546\u201355.","journal-title":"Arch Intern Med"},{"key":"BFaps201589_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1200\/JCO.2005.10.042","volume":"23","author":"JE Garber","year":"2005","unstructured":"Garber JE, Offit K . Hereditary cancer predisposition syndromes. J Clin Oncol 2005; 23: 276\u201392.","journal-title":"J Clin Oncol"},{"key":"BFaps201589_CR3","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"A Knudson","year":"1971","unstructured":"Knudson A . Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820\u20133.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFaps201589_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00439-011-1030-9","volume":"130","author":"CC Chung","year":"2011","unstructured":"Chung CC, Chanock SJ . Current status of genome-wide association studies in cancer. Hum Genet 2011; 130: 59\u201378.","journal-title":"Hum Genet"},{"key":"BFaps201589_CR5","first-page":"219","volume":"19","author":"HT Lynch","year":"1995","unstructured":"Lynch HT, Fusaro RM, Lynch J . Hereditary cancer in adults. Cancer Detect Prev 1995; 19: 219\u201333.","journal-title":"Cancer Detect Prev"},{"key":"BFaps201589_CR6","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0016-5085(99)70510-X","volume":"116","author":"HF Vasen","year":"1999","unstructured":"Vasen HF, Watson P, Mecklin JP, Lynch HT . \u201cNew clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC\u201d. Gastroenterology 1999; 116: 1453\u20136.","journal-title":"Gastroenterology"},{"key":"BFaps201589_CR7","first-page":"294","volume":"59","author":"Q Wang","year":"1999","unstructured":"Wang Q, Lasset C, Desseigne F, Frappaz D, Bergeron C, Navarro C, et al. Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res 1999; 59: 294\u20137.","journal-title":"Cancer Res"},{"key":"BFaps201589_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/jmedgenet-2014-102284","volume":"51","author":"K Wimmer","year":"2014","unstructured":"Wimmer K, Kratz CP, Vasen HF, Caron O, Colas C, Entz-Werle N, et al. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD). J Med Genet 2014; 51: 355\u201365.","journal-title":"J Med Genet"},{"key":"BFaps201589_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/ng.283","volume":"41","author":"MJ Ligtenberg","year":"2009","unstructured":"Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3\u2032 exons of TACSTD1. Nat Genet 2009; 41: 112\u20137.","journal-title":"Nat Genet"},{"key":"BFaps201589_CR10","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1093\/nar\/15.13.5323","volume":"15","author":"G Levinson","year":"1987","unstructured":"Levinson G, Gutman GA . High frequencies of short frameshifts in poly-CA\/TG tandem repeats borne by bacteriophage m13 in Escherichia coli k-12. Nucleic Acids Res 1987; 15: 5323\u201338.","journal-title":"Nucleic Acids Res"},{"key":"BFaps201589_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/S0168-9525(00)02139-9","volume":"16","author":"H Ellegren","year":"2000","unstructured":"Ellegren H . Microsatellite mutations in the germline: implications for evolutionary inference. Trends Genet 2000; 16: 551\u20138.","journal-title":"Trends Genet"},{"key":"BFaps201589_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/00001622-199507010-00013","volume":"7","author":"JR Eshleman","year":"1995","unstructured":"Eshleman JR, Markowitz SD . Microsatellite instability in inherited and sporadic neoplasms. Curr Opin Oncol 1995; 7: 83\u20139.","journal-title":"Curr Opin Oncol"},{"key":"BFaps201589_CR13","first-page":"5248","volume":"58","author":"CR Boland","year":"1998","unstructured":"Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, et al. National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998; 58: 5248\u201357.","journal-title":"Cancer Res"},{"key":"BFaps201589_CR14","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1053\/gast.2002.37070","volume":"123","author":"N Suraweera","year":"2002","unstructured":"Suraweera N, Duval A, Reperant M, Vaury C, Furlan D, Leroy K, et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology 2002; 123: 1804\u201311.","journal-title":"Gastroenterology"},{"key":"BFaps201589_CR15","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/jmedgenet-2014-102552","volume":"51","author":"K Newton","year":"2014","unstructured":"Newton K, Jorgensen NM, Wallace AJ, Buchanan DD, Lalloo F, McMahon RF, et al. Tumour MLH1 promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC). J Med Genet 2014; 51: 789\u201396.","journal-title":"J Med Genet"},{"key":"BFaps201589_CR16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/path.4419","volume":"234","author":"WR Geurts-Giele","year":"2014","unstructured":"Geurts-Giele WR, Leenen CH, Dubbink HJ, Meijssen IC, Post E, Sleddens HF, et al. Somatic aberrations of mismatch repair genes as a cause of microsatellite unstable cancers. J Pathol 2014; 234: 548\u201359.","journal-title":"J Pathol"},{"key":"BFaps201589_CR17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/humu.22740","volume":"36","author":"MO Joly","year":"2015","unstructured":"Joly MO, Attignon V, Saurin JC, Desseigne F, Leroux D, Martin-Denavit T, et al. Somatic MMR gene mutations as a cause for MSI-H sebaceous neoplasms in Muir-Torre Syndrome-Like patients. Hum Mutat 2015; 36: 292\u20135.","journal-title":"Hum Mutat"},{"key":"BFaps201589_CR18","first-page":"3230","volume":"61","author":"LA Loeb","year":"2001","unstructured":"Loeb LA . A mutator phenotype in cancer. Cancer Res 2001; 61: 3230\u20139.","journal-title":"Cancer Res"},{"key":"BFaps201589_CR19","first-page":"6046","volume":"61","author":"Y Mori","year":"2001","unstructured":"Mori Y, Yin J, Rashid A, Leggett BA, Young J, Simms L, et al. Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability. Cancer Res 2001; 61: 6046\u20139.","journal-title":"Cancer Res"},{"key":"BFaps201589_CR20","first-page":"977","volume":"35","author":"M Kawaguchi","year":"2009","unstructured":"Kawaguchi M, Banno K, Yanokura M, Kobayashi Y, Kishimi A, Ogawa S, et al. Analysis of candidate target genes for mononucleotide repeat mutation in microsatellite instability-high (MSI-H) endometrial cancer. Int J Oncol 2009; 35: 977\u201382.","journal-title":"Int J Oncol"},{"key":"BFaps201589_CR21","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/humu.20569","volume":"28","author":"J Auclair","year":"2007","unstructured":"Auclair J, Leroux D, Desseigne F, Lasset C, Saurin JC, Joly MO, et al. Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation. Hum Mutat 2007; 28: 1084\u201390.","journal-title":"Hum Mutat"},{"key":"BFaps201589_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/humu.20280","volume":"27","author":"J Auclair","year":"2006","unstructured":"Auclair J, Busine MP, Navarro C, Ruano E, Montmain G, Desseigne F, et al. Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing. Hum Mutat 2006; 27: 145\u201354.","journal-title":"Hum Mutat"},{"key":"BFaps201589_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/gcc.20842","volume":"50","author":"J Auclair","year":"2011","unstructured":"Auclair J, Vaissi\u00e8re T, Desseigne F, Lasset C, Bonadona V, Giraud S, et al. Intensity-dependent constitutional MLH1 promoter methylation leads to early onset of colorectal cancer by affecting both alleles. Intensity-dependent constitutional MLH1 promoter methylation leads to early onset of colorectal cancer by affecting both alleles. Genes Chromosomes Cancer 2011; 50: 178\u201385.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFaps201589_CR24","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/humu.20880","volume":"29","author":"SE Plon","year":"2008","unstructured":"Plon SE, Eccles DM, Foulkes WD, Genuardi M, Greenblatt MS, Hogervorst FBL, et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mut 2008; 29: 1282\u201391.","journal-title":"Hum Mut"},{"issue":"0","key":"BFaps201589_CR25","doi-asserted-by":"publisher","first-page":"bat036","DOI":"10.1093\/database\/bat036","volume":"2013","author":"P. Grandval","year":"2013","unstructured":"Grandval P, Fabre AJ, Gaildrat P, Baert-Desurmont S, Buisine MP, Ferrari A, et al. UMD-MLH1\/MSH2\/MSH6 databases: description and analysis of genetic variations in French Lynch syndrome families. Database. Vol. 2013, doi:10.1093\/database\/bat036.","journal-title":"Database"},{"key":"BFaps201589_CR26","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","volume":"62","author":"HFA Vasen","year":"2013","unstructured":"Vasen HFA, Blanco I, Aktan-Collan K, Gopie JP, Alonso A, Aretz S, et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 2013 62: 812\u201323.","journal-title":"Gut"},{"key":"BFaps201589_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/hmg\/6.1.105","volume":"6","author":"MG Dunlop","year":"1997","unstructured":"Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997; 6: 105\u201310.","journal-title":"Hum Mol Genet"},{"key":"BFaps201589_CR28","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/sj.ejhg.5201843","volume":"15","author":"F Alarcon","year":"2007","unstructured":"Alarcon F, Lasset C, Carayol J, Bonadona V, Perdry H, Desseigne F, et al. Estimating cancer risk in HNPCC by the GRL method. Eur J Hum Genet 2007; 15: 831\u20136.","journal-title":"Eur J Hum Genet"},{"key":"BFaps201589_CR29","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1001\/jama.2011.743","volume":"305","author":"V Bonadona","year":"2011","unstructured":"Bonadona V, Bona\u00efti B, Olschwang S, Grandjouan S, Huiart L, Longy M, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA 2011; 305: 2304\u201310.","journal-title":"JAMA"},{"key":"BFaps201589_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10689-013-9614-2","volume":"12","author":"BA Talseth-Palmer","year":"2013","unstructured":"Talseth-Palmer BA, Wijnen JT, Grice DM, Scott RJ . Genetic modifiers of cancer risk in Lynch syndrome: a review. Familial Cancer 2013; 12: 207\u201316.","journal-title":"Familial Cancer"},{"key":"BFaps201589_CR31","first-page":"5849","volume":"53","author":"RA Lothe","year":"1993","unstructured":"Lothe RA, Peltom\u00e4ki P, Meling GI, Aaltonen LA, Nystr\u00f6m-Lahti M, Pylkk\u00e4nen L, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993; 53: 5849\u201352.","journal-title":"Cancer Res"},{"key":"BFaps201589_CR32","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1038\/sj.bjc.6602534","volume":"92","author":"A Buckowitz","year":"2005","unstructured":"Buckowitz A, Knaebel HP, Benner A, Bl\u00e4ker H, Gebert J, Kienle P, et al. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br J Cancer 2005; 92: 1746\u201353.","journal-title":"Br J Cancer"},{"key":"BFaps201589_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nrclinonc.2009.235","volume":"7","author":"FA Sinicrope","year":"2010","unstructured":"Sinicrope FA . DNA mismatch repair and adjuvant chemotherapy in sporadic colon cancer. Nat Rev Clin Oncol 2010; 7: 174\u20137.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFaps201589_CR34","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1055\/s-0032-1313783","volume":"25","author":"G Yacoub","year":"2012","unstructured":"Yacoub G, Nagalla S, Aklilu M . Oncologic management of hereditary colorectal cancer. Clin Colon Rectal Surg 2012; 25: 118\u201322.","journal-title":"Clin Colon Rectal Surg"},{"key":"BFaps201589_CR35","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1038\/sj.onc.1206678","volume":"22","author":"SN Powell","year":"2003","unstructured":"Powell SN, Kachnic LA . Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Oncogene 2003; 22: 5784\u201391.","journal-title":"Oncogene"},{"key":"BFaps201589_CR36","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1101\/gad.14.8.927","volume":"14","author":"Y Wang","year":"2000","unstructured":"Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J . BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 2000; 14: 927\u201339.","journal-title":"Genes Dev"},{"key":"BFaps201589_CR37","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"105","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, et al. Cancer risks for BRCA1 and BRCA2 mutation carriers. Results from prospective analysis of EMBRACE. J Natl Cancer Inst 2013; 105: 812\u201322.","journal-title":"J Natl Cancer Inst"},{"key":"BFaps201589_CR38","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/283593a0","volume":"283","author":"BW Durkacz","year":"1980","unstructured":"Durkacz BW, Omidiji O, Gray DA, Shall S . (ADP-ribose)n participates in DNA excision repair. Nature 1980; 283: 593\u20136.","journal-title":"Nature"},{"key":"BFaps201589_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1073\/pnas.81.1.243","volume":"81","author":"C Borek","year":"1984","unstructured":"Borek C, Morgan WF, Ong A, Cleaver JE . Inhibition of malignant transformation in vitro by inhibitors of poly(ADP-ribose) synthesis. Proc Natl Acad Sci U S A 1984; 81: 243\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFaps201589_CR40","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1080\/09553008614551381","volume":"50","author":"PJ Thraves","year":"1986","unstructured":"Thraves PJ, Mossman KL, Brennan T, Dritschilo . Differential radiosensitization of human tumour cells by 3-aminobenzamide and benzamide: inhibitors of poly(ADP-ribosylation). Int J Radiat Biol Relat Stud Phys Chem Med 1986; 50: 961\u201372.","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"key":"BFaps201589_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa0900212","volume":"361","author":"PC Fong","year":"2009","unstructured":"Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 2009; 361: 123\u201334.","journal-title":"N Engl J Med"},{"key":"BFaps201589_CR42","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ygyno.2014.02.039","volume":"133","author":"JF Liu","year":"2014","unstructured":"Liu JF, Konstantinopoulos PA, Matulonis UA . PARP inhibitors in ovarian cancer: Current status and future promise. Gynecol Oncol 2014; 133: 362\u20139.","journal-title":"Gynecol Oncol"},{"key":"BFaps201589_CR43","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.1200\/JCO.2008.16.1703","volume":"25","author":"DS Tan","year":"2008","unstructured":"Tan DS, Rothermundt C, Thomas K, Bancroft E, Eeles R, Shanley S, et al. \u201cBRCAness\u201d syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations. J Clin Oncol 2008; 25: 5530\u20136.","journal-title":"J Clin Oncol"},{"key":"BFaps201589_CR44","doi-asserted-by":"publisher","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","volume":"66","author":"N McCabe","year":"2006","unstructured":"McCabe N, Turner NC, Lord CJ, Kluzek K, Bialkowska A, Swift S, et al. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition. Cancer Res 2006; 66: 8109\u201315.","journal-title":"Cancer Res"},{"key":"BFaps201589_CR45","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1097\/CCO.0b013e3283499da9","volume":"23","author":"KC Long","year":"2011","unstructured":"Long KC, Kauff ND . Hereditary ovarian cancer: recent molecular insights and their impact on screening strategies. Curr Opin Oncol 2011; 23: 526\u201330.","journal-title":"Curr Opin Oncol"},{"key":"BFaps201589_CR46","doi-asserted-by":"publisher","first-page":"18032","DOI":"10.1073\/pnas.1115052108","volume":"108","author":"T Walsh","year":"2011","unstructured":"Walsh T, Casadei S, Lee MK, Pennil CC, Nord AS, Thornton AM, et al. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci U S A 2011; 108: 18032\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFaps201589_CR47","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1200\/JCO.2009.27.5719","volume":"28","author":"PA Konstantinopoulos","year":"2010","unstructured":"Konstantinopoulos PA, Spentzos D, Karlan BY, Taniguchi T, Fountzilas E, Francoeur N, et al. Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer. J Clin Oncol 2010; 28: 3555\u20136.","journal-title":"J Clin Oncol"},{"key":"BFaps201589_CR48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/ng.2007.39","volume":"40","author":"LH Saal","year":"2008","unstructured":"Saal LH, Gruvberger-Saal SK, Persson C, L\u00f6vgren K, Jumppanen M, Staaf J, et al. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet 2008; 40: 102\u20137.","journal-title":"Nat Genet"},{"key":"BFaps201589_CR49","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrclinonc.2011.42","volume":"8","author":"MD Forster","year":"2011","unstructured":"Forster MD, Dedes KJ, Sandhu S, Frentzas S, Kristeleit R, Ashworth A, et al. Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer. Nat Rev Clin Oncol 2011; 8: 302\u20136.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFaps201589_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1472-6890-13-33","volume":"13","author":"P Joost","year":"2013","unstructured":"Joost P, Bendahl PO, Halvarsson B, Rambech E, Nilbert M . Efficient and reproducible identification of mismatch repair deficient colon cancer: validation of the MMR index and comparison with other predictive models. BMC Clin Pathol 2013; 13: 33.","journal-title":"BMC Clin Pathol"},{"key":"BFaps201589_CR51","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10549-014-3100-x","volume":"147","author":"T Byrski","year":"2014","unstructured":"Byrski T, Huzarski T, Dent R, Marczyk E, Jasiowka M, Gronwald J, et al. Pathologic complete response to neoadjuvant cisplatin in BRCA1-positive breast cancer patients. Breast Cancer Res Treat 2014; 147: 401\u20135.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps201589.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201589","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201589.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:33:34Z","timestamp":1684413214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps201589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,30]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["BFaps201589"],"URL":"https:\/\/doi.org\/10.1038\/aps.2015.89","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,30]]},"assertion":[{"value":"23 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}